RegisterLogin

C215

CAT: 0804-HY-124814-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-124814-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
C215 is a potent inhibitor of MmpL3. C215 is identified in HTS with glycerol independent activity against M. tuberculosis, limited non-specific toxicity against mammalian cells, an IC90 of 16 μM against M. tuberculosis, and efficacy against M. tuberculosis growing in macrophages[1].
CAS Number
[912780-51-9]
UNSPSC
12352005
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/c215.html
Purity
99.63
Solubility
DMSO : 62.5 mg/mL (ultrasonic)
Smiles
CCCN1C2=CC=C(NCC3=CC=C(Cl)C=C3Cl)C=C2N=C1
Molecular Formula
C17H17Cl2N3
Molecular Weight
334.24
References & Citations
[1]Stanley SA, Grant SS, Kawate T, et al. Identification of novel inhibitors of M. tuberculosis growth using whole cell based high-throughput screening. ACS Chem Biol. 2012;7 (8) :1377-1384.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P1182C21

Alternative Products

CatalogName
BA1540-10C215
C215Xpert PML-RARA Control Panel C215
MBS1196880-01Recombinant Schizosaccharomyces pombe UPF0743 protein C215.06c (SPBC215.06c)
MBS1134214-01Recombinant Schizosaccharomyces pombe Uncharacterized oxidoreductase C215.11c (SPBC215.11c)
MBS1174033-01Recombinant Schizosaccharomyces pombe Uncharacterized hydrolase C215.10 (SPBC215.10)
MBS1195328Recombinant Schizosaccharomyces pombe Uncharacterized serine-rich protein C215.13 (SPBC215.13), partial
MBS1083214Recombinant Schizosaccharomyces pombe TBC domain-containing protein C215.01 (SPBC215.01, SPBC3B9.20), partial

Popular Products